Show simple item record

dc.contributor.authorHernar, I
dc.contributor.authorGraue, M
dc.contributor.authorStrandberg, RB
dc.contributor.authorLie, SS
dc.contributor.authorSigurdardottir, AK
dc.contributor.authorRichards, DA
dc.contributor.authorKolltveit, BH
dc.contributor.authorHaugstvedt, A
dc.date.accessioned2021-02-17T10:43:13Z
dc.date.issued2021-02-05
dc.description.abstractAim To explore young adults' experiences of outpatient follow‐up appointments, completing electronic Patient‐Reported Outcome Measures (PROMs), and using the Problem Areas In Diabetes (PAID) scale during the Diabetes Patient‐Reported Outcome Measures (DiaPROM) pilot trial. Methods We performed a qualitative study among 19 young adults (aged 22–39 years) with type 1 diabetes who participated in the pilot trial. Between February and June 2019, we conducted individual, semi‐structured telephone interviews with participants from the intervention and control arms. We analysed the data using thematic analysis. Results Our analyses generated three themes, each with two subthemes: (1) Follow‐up with limitations; (i) Marginal dialogue about everyday challenges, (ii) Value of supportive relationships and continuity, indicate that previous follow‐up had been experienced as challenging and insufficient. (2) New insights and raised awareness; (i) More life‐oriented insights, (ii) Moving out of the comfort zone, suggest mostly positive experiences with completing questionnaires and discussing the PAID scores. (3) Addressing problem areas with an open mind; (i) Need for elaboration, (ii) Preparedness for dialogue, indicate that both openness and explanations were vital in the follow‐up. Conclusions Participants characterised the previous follow‐up as challenging and insufficient. They described completing and using the PAID as somewhat uncomfortable yet worthwhile. Our findings also suggest that by utilising diabetes distress data alongside health and biomedical outcomes, consultations became more attuned to the young adults' wishes and needs, mainly because the dialogue was more focused and direct. Hence, the PAID has the potential to facilitate person‐centredness and improve patient–provider relationships.en_GB
dc.description.sponsorshipNational Institute for Health Research (NIHR)en_GB
dc.description.sponsorshipWestern Norway University of Applied Sciences
dc.description.sponsorshipNorwegian Nurses Association
dc.description.sponsorshipNorwegian Diabetes Association
dc.identifier.citationPublished online 5 February 2021en_GB
dc.identifier.doi10.1111/dme.14535
dc.identifier.urihttp://hdl.handle.net/10871/124772
dc.language.isoenen_GB
dc.publisherWiley / Diabetes UKen_GB
dc.rights© 2021 The Authors. Diabetic Medicine published by John Wiley & Sons Ltd on behalf of Diabetes UK. This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.en_GB
dc.subjectdiabetes mellitusen_GB
dc.subjectempowermenten_GB
dc.subjectoutpatient careen_GB
dc.subjectpatient-centred careen_GB
dc.subjectprofessional–patient relationsen_GB
dc.subjectself reporten_GB
dc.subjecttype 1 adulten_GB
dc.titleYoung adults with type 1 diabetes and their experiences with diabetes follow‐up and participation in the DiaPROM pilot trial: a qualitative studyen_GB
dc.typeArticleen_GB
dc.date.available2021-02-17T10:43:13Z
dc.identifier.issn0742-3071
dc.descriptionThis is the final version. Available on open access from Wiley via the DOI in this record. en_GB
dc.identifier.eissn1464-5491
dc.identifier.journalDiabetic Medicineen_GB
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/en_GB
dcterms.dateAccepted2021-02-02
exeter.funder::National Institute for Health Research (NIHR)en_GB
rioxxterms.versionVoRen_GB
rioxxterms.licenseref.startdate2021-02-05
rioxxterms.typeJournal Article/Reviewen_GB
refterms.dateFCD2021-02-17T10:36:14Z
refterms.versionFCDVoR
refterms.dateFOA2021-02-17T10:43:20Z
refterms.panelAen_GB


Files in this item

This item appears in the following Collection(s)

Show simple item record

© 2021 The Authors. Diabetic Medicine published by John Wiley & Sons Ltd on behalf of Diabetes UK.

This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
Except where otherwise noted, this item's licence is described as © 2021 The Authors. Diabetic Medicine published by John Wiley & Sons Ltd on behalf of Diabetes UK. This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.